A retrospective single-center study to determine long-term tolerability of belatacept in both de novo and conversion regimens in kidney transplant recipients
Latest Information Update: 07 Jul 2021
At a glance
- Drugs Belatacept (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 07 Jul 2021 New trial record
- 09 Jun 2021 Results presented at the 2021 American Transplant Congress